Search
for
Sort by
Research 30 of 1000+
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Diagnostic challenges in determining alopecia areata
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- Lupus erythematosus: systemic and cutaneous manifestations
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Adverse Effects and Drug Interactions of Biologic Agents
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Cutaneous drug reactions
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- SP0227 Case 1 Presentation: Arthritis, Lupus and More. Rhupus or Polyautoimmunity?
- Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Folliculitis decalvans managed with adalimumab: A case report
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Alopecia areata after denosumab treatment for osteoporosis
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- TOC
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Medications
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Weight Gain and Hair Loss during Anti-TNF Therapy
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab